Oxidative stress attributable to the activation of a Nox2-containing NADPH oxidase is involved in the development of vascular diseases and in aging. However, the mechanism of Nox2 activation in normal aging remains unclear. In this study, we used age-matched wild-type (WT) and Nox2 knockout (KO) mice at 3-4 months (young); 11-12 months (middle-aged) and 21-22 months (aging) to investigate age-related metabolic disorders, Nox2 activation and endothelial dysfunction. Compared to young mice, middle-aged and aging WT mice had significant hyperglycaemia, hyperinsulinaemia, increased systemic oxidative stress and higher blood pressure. Endothelium-dependent vessel relaxation to acetylcholine was significantly impaired in WT aging aortas, and this was accompanied by increased Nox2 and ICAM-1 expressions, MAPK activation and decreased insulin receptor expression and signaling. However, these aging-associated disorders were significantly reduced or absent in Nox2KO aging mice. The effect of metabolic disorder on Nox2 activation and endothelial dysfunction was further confirmed using high-fat diet-induced obesity and insulin resistance in middle-aged WT mice treated with apocynin (a Nox2 inhibitor). In vitro experiments showed that in response to high glucose plus high insulin challenge, WT coronary microvascular endothelial cells increased significantly the levels of Nox2 expression, activation of stress signaling pathways and the cells were senescent, e.g. increased p53 and β-galactosidase activity. However, these changes were absent in Nox2KO cells. In conclusion, Nox2 activation in response to aging-associated hyperglycaemia and hyperinsulinaemia plays a key role in the oxidative damage of vascular function. Inhibition or knockout of Nox2 preserves endothelial function and improves global metabolism in old age.
Introduction
Age is recognized as a major risk factor for cardiovascular diseases. High prevalence of obesity and insulin resistance in an aging population has led to a rapid increase in type-2 diabetes and cardiovascular diseases [1] [2] [3] . An early feature in the development of metabolic and cardiovascular diseases is the progressive endothelial dysfunction attributable to increased reactive oxygen species (ROS) production by a Nox2-containing NADPH oxidase [2, [4] [5] [6] [7] [8] . Oxidative stress causes DNA damage, alters transcriptional machinery and promotes inflammatory gene expressions. All these are key factors that further accelerate vascular aging [2] .
NADPH oxidase is a multicomponent enzyme. The catalytic subunit of NADPH oxidase has been found to have 7 isoforms (Nox1-5, and Duox 1-2) [9, 10] . Among these Nox isoforms, Nox2 is highly expressed in both inflammatory phagocytic cells and vascular endothelial cells [9, 10] . Unlike the other Nox isoforms, Nox2 requires p22 phox and several regulatory subunits i.e. p40 phox , p47 phox p67 phox and rac1 for O 2 .-production [11] . In response to stimuli, such as high glucose, oxidized LDL and inflammatory cytokines, endothelial Nox2 is activated and produces excessive levels of ROS, which outstrips the endogenous antioxidant defense and causes oxidative damage to the endothelium and the organs [7, 8] . Transgenic mice with endothelialspecific Nox2 overexpression had high levels of ROS production and ERK1/2 activation in the endothelium [7] , and there is a close relationship between the levels of endothelial oxidative stress and the degree of insulin resistance and cardiovascular disorders found in experimental animals and in humans [4, 6, 12] . However, the mechanism of Nox2 activation in normal aging remains unclear.
In this study, we used littermates of age-matched wild-type (WT) and Nox2 knockout (Nox2KO) mice in young (3-4 m); middle-aged (11-12 m) and old age (21-22 m) to investigate the mechanism of aging-associated Nox2 activation and global oxidative stress. In particular, we examined the relationship between the levels of aging-related glucose metabolic disorders and endothelial Nox2 activation in aorta inflammation, decline of insulin receptor expression and endothelial dysfunction. The critical role of metabolic disorder in Nox2 activation and endothelial dysfunction was further examined using a model of high-fat diet-induced obesity and insulin resistance in middle-aged WT mice treated with or without apocynin (a Nox2 inhibitor). We also examined the mechanisms of high glucose and insulin-induced Nox2 activation and redox-signaling in endothelial cell senescence and apoptosis using coronary microvascular endothelial cells (CMEC) isolated from WT and Nox2KO mice. Our study for the first time demonstrated a crucial role of global Nox2 activation in response to aging associated glucose metabolic disorders (i.e. hyperglycaemia and hyperinsulineamia) causing inflammation and oxidative damage of endothelial function and insulin receptor function in major vessels. Inhibition or knockout of Nox2 helps to preserve endothelial function and improves global metabolism in old age.
Materials and methods

Reagents
Polyclonal antibodies against Nox1, Nox2, Nox4, p22 phox , p40 phox , p47 phox , p67 phox , rac1, insulin receptors (IRα and IRβ) were from Santa Cruz Biotechnology. Antibodies to phospho-ERK1/2, phosphop38MAPK, phospho-JNK and phospho-Akt ser473 were from Cell Signaling Technology. DHE (dihydroethidium) and 5-(and 6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (DCF) were from Invitrogen (UK). All other reagents and chemicals were from Sigma unless stated otherwise.
Animals
All studies were performed in accordance with the protocols approved by the Home Office under the Animals (Scientific Procedures) Act 1986, UK. Nox2 knockout mice on a C57BL/6J background were originally obtained from Jackson Laboratory, USA. These mice were generated by insertion of an expression cassette for neomycin resistance into exon 3 of the Nox2 gene (Cybb) and attaching a flanking herpes thymidine kinase gene [13] . Nox2KO mice lack phagocyte superoxide production and manifest an increased susceptibility to infection. Littermates of WT and Nox2KO mice were bred in our institution from heterozygotes and genotyped. Animals were housed under standard conditions with a 12:12 light dark cycle and food and water were available ad libitum. Male mice were randomly grouped and used at young (3-4 m), middle age (11-12 m) and old age (21-22 m) . A total of 12-15 mice were used per group. Body weights were measured monthly. The measurement of food intake was for a period of 3 days while the animals were individually housed and repeated every month.
2.3. High-fat diet-induced obesity and insulin resistance in middle-aged mice treated with or without apocynin
Littermates of WT and Nox2KO male mice at 8 m of age were randomly assigned (n=10/per group) to a high-fat diet (HFD group): 45% kcal fat, 20% kcal protein, and 35% kcal carbohydrate (Special Diets Services, UK), or a normal chow diet (control group): 3% kcal fat, 25.9% kcal protein, and 64.8% kcal carbohydrate (LabDiet Ltd., UK) for 16 weeks. Apocynin was supplied in drinking water (5 mM). Food intake and body weights were measured as described above. Mice were used at the age of 12 m.
Metabolic measurements and intraperitoneal glucose tolerance test (IPGTT)
These were performed as described previously [8] . Serum glucose was measured at 9 a.m. after 8 h of fasting using a blood glucose meter (Accu-Chek, UK). Fasting plasma insulin was measured using a mouse insulin enzyme-linked immunosorbent assay kit (Mercodia Developing Diagnostic, Sweden). Fasting serum cholesterol, FFA, triglyceride, and high-density-lipoprotein (HDL) cholesterol were measured by enzymatic colorimetric assays using an ILab 650 Chemistry System. LDL cholesterol was calculated as the difference between total and HDL cholesterol concentrations based on the Friedewald equation [14] . For the IPGTT, mice were fasted for 8 h before an intraperitoneal injection (IP) of glucose (2 g kg −1 body weight) was administrated. Blood glucose was then measured at 15, 30, 60 and 120 min after injection.
Blood pressure (BP) and endothelial function assessments
These were performed exactly as described previously [8] . BP was measured by a computer controlled non-invasive tail-cuff BP system (Kent Scientific Corporation, USA) on conscious mice at 10 am, and measurements were recorded by the CODA™ program. The mean of at least 6 successful recordings was used for each mouse. For the assessment of endothelial function, freshly excised thoracic aortic rings (3-4 mm in length) were suspended in an organ bath (ML0146/C-V, AD Instrument Ltd) at 37°C containing 10 ml of Krebs-Henseleit solution (in mmol/L: NaCl 119, KCl 4.7, KH 2 PO 4 1.2, MgSO 4 1.2, CaCl 2 2.5, NaHCO 3 25, glucose 11.1, pH 7.4) gassed with 95% O 2 /5% CO 2 . The cumulative dose response to phenylephrine (PE) (1 nmol/L to 10 μmol/ L) was assessed first. After washing and re-equilibration, relaxation responses to sodium nitroprusside (SNP, 0.1 nmol/L to 1 μmol/L) or acetylcholine (Ach, 1 nmol/L to 10 μmol/L) were assessed in rings preconstricted to ∼70% of their maximal PE-induced tension. Relaxation was expressed as the percentage of pre-constricted tension. Some experiments were performed in the presence of tiron (10 mmol/L) or the nitric oxide synthase (NOS) inhibitor, Nω-Nitro-L-arginine methyl ester (L-NAME, 100 µmol/L).
Coronary microvascular endothelial cell (CMEC) isolation
CMECs were isolated from the hearts of middle-aged (11-12 m) WT and Nox2KO mice according to the method reported previously [15] . Six hearts were used for each CMEC isolation. CMECs were cultured in DMEM supplemented with 10% FBS, EC growth supplement (30 µg/ ml), epidermal growth factor (10 ng/ml), vascular endothelial growth factor (0.5 ng/ml), ascorbic acid (1 µg/ml), hydrocortisone (1 µg/ml), L-glutamine (2 mmol/L), penicillin (50 U/ml) and streptomycin (50 µg/ ml). CMECs were used at passage 2.
2.7. In situ detection of senescence-associated β-galactosidase (SAβG) activity
The SAβG activity (a cell senescence marker) in cultured CMECs was performed as described previously [16] . Briefly, cells were cultured on chamber slides and treated according to the experimental design. After fixation with 1% ice-cold paraformaldehyde and washing in PBS, cells were incubated with freshly prepared staining buffer containing 40 mmol/L citric acid/sodium (pH 6.0), 0.15 mol/L NaCl, 2 mmol/L MgCl 2 , 5 mmol/L potassium ferrocyanide, 1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl β-D-galactoside). The SAβG positive cells (blue) were examined microscopically at ×200 magnification and counted.
TUNEL assay
The TUNEL assay was performed as described previously [17] . Briefly, endothelial cells were cultured onto the chamber slide, and stimulated with high glucose plus insulin for 24 h. The cells were then washed and fixed in 2% methanol-free formaldehyde/PBS solution, and treated with 0.2% Triton® X-100/PBS solution for 5 min. The TUNEL assay was performed using the DeadEnd fluorometric technique (Promega, UK) following the protocol of the manufacturer and visualised under fluorescence microscopy. were identified using inhibitors targeting NOS (L-NAME 100 μmol/L),
ROS measurement
DHE (or DCF) images were captured digitally and acquired using an Olympus BX61 fluorescence microscope. The fluorescence intensity was quantified from at least 5 random fields (269.7×269.2 µm) per section with 3 sections/sample and 6 animals/group. Nitric oxide (NO) production was assessed by measuring the concentration of serum nitrite, which is one of the primary stable and nonvolatile breakdown products of NO using the Griess assay kit from Promega UK.
Immunoblotting
This was performed exactly as described previously [8, 20] . The images were captured digitally using a BioSpectrum AC imaging system (UVP, UK), and the optical densities of the protein bands were normalized to the loading control bands and quantified.
Immunofluorescence microscopy
The experiments were performed exactly as described previously [8, 20] . Primary antibodies were used at 1:250 dilution and biotinconjugated anti-rabbit or anti-goat (1:1000 dilution) were used as secondary antibodies. Specific binding of antibodies was detected by extravidin-FITC or streptavidin-Cy3. Normal rabbit or goat IgG (5 µg/ ml) was used instead of primary antibody as a negative control. Images were acquired with an Olympus BX61 fluorescence microscope system. Fluorescence intensities were quantified as described above.
Statistical analysis
Statistical analysis was performed using one-way or two-way analysis of variance (ANOVA) followed by Bonferroni post-hoc tests except where it was specified in the figure legend. The data were from at least 9-13 mice/group and expressed as mean ± SD except where specified in the figure legend. P < 0.05 was considered statistically significant.
Results
Aging-associated metabolic disorders and insulin resistance
There was no significant difference in the amount of food intake, heart weight/body weight ratios and serum nitrite levels (an indicator of NO metabolism) between age groups of WT and Nox2KO mice ( Fig. 1A) . At young age (3-4 m), there was no significant difference between WT and Nox2KO mice for all of the parameters examined ( Fig. 1A-B) . However, WT mice had significantly greater body weight, epididymal fat weight and blood pressure starting at middle age (11-12 m) and progressing to old age (21-22 m). Compared to agematched WT mice, age-related increases in body and epididymal fat weights were significantly reduced in Nox2KO mice. Blood pressure was well maintained in Nox2KO mice without any significant differences between age groups (Fig. 1A) .
The levels of fasting serum non-essential free fatty acids (NEFA) and triglyceride were well maintained without significant age-related differences between WT and Nox2KO mice (Fig. 1B) . However, the levels of fasting serum total cholesterol, LDL, glucose and insulin increased as age progressed and were statistically significant at oldage in comparison to young mice in WT mice, but not in Nox2KO mice. Insulin resistance in aging WT mice was further confirmed by glucose tolerance tests (Fig. 1C ).
Knockout Nox2 abolished aging-associated increase in ROS production in multiple organs
Age-related systemic oxidative stress was examined by measuring the levels of NADPH-dependent O 2 .-production using organ homogenates by lucigenin (5 µM)-chemiluminescence ( Fig. 2) . In WT mice, the levels of O 2 .-production in different organs varied with the highest levels found in the bone marrow and the liver. There were significant increases in the levels of O 2 .-production starting at middle age and progressing to old-age in the heart, lung, liver, kidney, aorta, spleen, fat, brain and the bone marrow (except skeletal muscles) of WT mice, but not in the organs of Nox2KO mice. In fact, the Nox2KO bone marrow, spleen and fat tissue had very little (just detectable) O 2 .-production. The skeletal muscle produced low levels of O 2 .-production without significant difference between age groups of both WT and Nox2KO mice.
Aging-associated endothelial dysfunction in WT but not in Nox2KO mice
The vascular function was examined ex vivo using freshly isolated aortic sections in an organ bath. There were no significant differences in the vessel contractile responses to phenylephrine (PE) between WT and Nox2KO mice of all age groups (Figs. 3A and 3E). At young age, there were no significant differences in endothelium-dependent vessel relaxation to acetylcholine (Ach) between WT and Nox2KO mice. However, the endothelium-dependent vessel relaxation response to acetylcholine started to reduce at middle-age and was significantly impaired at old age (Fig. 3B) , which could be corrected back to levels of the young mice by adding tiron (an O 2 .-scavenger) suggesting a role for O 2 .- (Fig. 3B ).
The endothelium-dependent vessel relaxation to Ach (Fig. 3B) was completely blocked by adding L-NAME, an inhibitor of endothelial nitric oxide synthase (eNOS) indicating that Ach-induced vessel relaxation was depending on endothelial release of NO (Fig. 3 C) . However, the smooth muscle relaxation response to SNP (a NO donor) was not affected by age (Fig. 3D) . The significance in reduced endotheliumdependent response to Ach in WT aging mice was further confirmed by EC50 values (Fig. 3E ).
3.4. Aging-associated activation of Nox2, stress signaling pathways, VCAM-1 expression and damage of insulin receptor expression in aortas
To further define a role for Nox2 in the oxidative regulation of aging aorta function, we examined the aorta expression of Nox subunit by Western blot (Fig. 4A) phox and rac1/2 between young and aging Nox2KO aortas; instead, aging Nox2KO aortas had a significant increase in Nox4 expression as compared to young Nox2KO controls (Fig. 4A) . Although the levels of Nox1 expression showed a pattern of age-related increase, the difference between young and aging groups was not statistically significant for both WT and Nox2KO mice. We then examined the difference in redox-sensitive ERK1/2, p38MAPK and JNK phosphorylation in aortic samples using phosphorylation-specific monoclonal antibodies. The levels of total protein detected in the same samples were used as loading controls (Fig. 4B) . 
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Compared to young WT aortas, the levels of ERK1/2 phosphorylation were increased significantly, whereas the levels of p38MAPK phosphorylation were decreased significantly in aging WT aortas (Fig. 4B) . However, there was no significant difference in ERK1/2 and p38MAPK phosphorylation between young and aging aortas of Nox2KO mice. The levels of phosphorylated JNK were very low and showed no significant change between age groups of WT and Nox2KO aortas. Putting everything together, our data strongly suggest a crucial role for ageassociated Nox2 activation in the activation of redox signaling pathways in aging WT aortas. To explore any relationship between Nox2-derived oxidative stress, inflammation and vascular insulin resistance in aging aortas, we examined the levels of expression of vascular cell adhesion molecule 1 (VCAM-1, an inflammation marker), the expression of insulin receptor and the levels of AKT phosphorylation (a key molecule involved in the insulin signaling pathway) in aortic homogenates by Western blot (Fig. 4C) . There was no significant difference in the expression of these molecules at the young age between WT and Nox2KO aortas. However, there was a significant increase in the VCAM-1 expression in aging WT aortas, which was accompanied by significant decreases in insulin receptor (both IRα and IRβ) expression and AKT phosphorylation in comparison to the levels in young WT aortas, (Fig. 4C) . These changes were absent in Nox2KO aging aortas. 
In situ detection of ROS production, Nox2 expression, inflammation and oxidative damage of insulin receptor expression in aging aortas
Increased ROS production in the aging aorta was further examined in situ by DHE fluorescence on aortic sections (Fig. 5A) . Tiron was used to confirm the detection of O 2 .-. Compared to young WT vessels, there was a significant increase in DHE fluorescence throughout the aortic wall of WT aging mice, which was significantly reduced by adding tiron. In contrast, there was no significant increase in DHE fluorescence in Nox2KO aging aortas as compared to young Nox2KO aortas. 
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In order to confirm an increased endothelial Nox2 expression in aging aortas, we labelled the endothelium with CD31 (an endothelial cell marker, red fluorescence) and detected Nox2 expression (green fluorescence) in aortic sections. Nuclei were labelled with DAPI (blue fluorescence) to visualize the cells (Fig. 5B) . Nox2 was weakly detectable in WT young aortas and was mainly present in the adventitia. Compared to WT young aortas, there was a significant increase in endothelial Nox2 expression in aging WT aortas as indicated by the yellow fluorescence (Fig. 5B) .
Endothelial inflammation was further examined by the expression of intercellular adhesion molecule-1 (ICAM-1, red) and infiltrating leucocytes (labelled with CD45, green) (Fig. 5C) . At young age, the level of ICAM-1 expression was low and mainly detected in the endothelium and adventitia without significant difference between WT and Nox2KO mice; CD45-positive cells were almost undetectable in the aortic wall of both WT and Nox2KO young mice. However, at old age, there was a remarkable increase in the levels of ICAM-1 expression in the endothelium of WT aortas, and this was accompanied by CD45-positive leucocyte infiltration throughout the vessel wall predominately around the endothelium as indicated by the yellow fluorescence (Fig. 5C ). However, these inflammatory changes were significantly reduced in Nox2KO aging aortas.
We then examined the aorta insulin receptor expression (Fig. 5D ). Insulin receptor α was detected throughout the aortic wall without significant difference at young age between WT and Nox2KO mice. Compared to young WT aortas, the expression of insulin receptor α was reduced significantly in WT aging aortas mainly in the endothelium and the media. However, insulin receptor expression was well preserved in aging Nox2KO aortas.
Metabolic disorder-induced Nox2 activation and oxidative damage of endothelial function in high fat diet (HFD)-induced obesity and insulin resistance treated with or without apocynin
High-fat diet-induced mouse model of obesity and insulin resistance has been shown to display an accelerated aging phonotype and increased levels of oxidative stress/damage in organ function [21] . Therefore, it would be a good model for us to examine the effects of metabolic disorders on Nox2 activation and endothelial dysfunction. Compared to control chow diet-fed mice, WT mice under HFD increased significantly the body weight and blood pressure together with high levels of fasting serum glucose and insulin (Fig. 6A) . However, these changes were significantly reduced after apocynin treatment.
We then examined the Nox2 expression in aortas by immunofluorescence. Compared to control vessels, HFD up-regulated significantly the Nox2 expression (green colour) in the aorta wall mainly in the endothelium (labelled by CD31 in red) and the adventitia (Fig. 6B) . Apocynin treatment had no statistically significant effect on aorta Nox2 expression (Fig. 6B, right panel) . Aortas of HFD mice had significantly higher levels of NADPH-dependent O 2 .-production as examined by both lucigenin-chemiluminescence and SOD-inhibitable cytochrome c reduction assay, and these were significantly inhibited by apocynin-treatment (Fig. 6C) . The endothelium-dependent vessel relaxation to acetylcholine was attenuated in HFD WT aortas, and this was well preserved in HFD mice treated with apocynin (Fig. 6D) . The impairment of endothelium-dependent vessel relaxation to acetylcholine in HFD WT aorta was inhibited by MnTMPyP (a cell permeable SOD mimic), which further confirmed the role of ROS in mediating HFDinduced endothelial dysfunction (Fig. 6D, right panel) .
High glucose and insulin-induced endothelial Nox2 activation and oxidative signaling in endothelial cell senescence and apoptosis
Hyperglycaemia and hyperinsulinaemia-induced Nox2 activation and stress signaling in endothelial aging was further examined using CMECs isolated from middle-aged (11-12 m) WT and Nox2KO mice.
Cells were challenged with high glucose (25 mmol/L) plus insulin (1.2 nmol/L) for 24 h and examined for NADPH-dependent O 2 .-production (Fig. 7A ). Compared to vehicle-stimulated control cells, high glucose/insulin significantly increased the levels of O 2 .-production in WT cells (Fig. 7A, left panel) , and this was inhibited significantly by tiron and DPI (a flavoprotein inhibitor), but not by L-NAME (NOS inhibitor), rotenone (mitochondria complex 1 enzyme inhibitor) nor oxypurinol (xanthine oxidase inhibitor) (Fig. 7A, right panel) . Increased ROS production by WT CMECs was accompanied by significant increases in the levels of Nox2 expression, ERK1/2 phosphorylation and p53 (cell apoptosis-related gene product) expression (Fig. 7B) . In contrast, Nox2KO CMECs failed ROS response to high glucose/insulin challenge (Fig. 7A, middle panel) , and the ERK1/2 and p53 activation were inhibited or absent in Nox2KO cells (Fig. 7B) . The role of Nox2-derived ROS in mediating endothelial senescence and apoptosis was examined by SAβG activity and TUNEL assay, respectively (Fig. 7C) . In comparison to WT control cells, high glucose/insulin challenge significantly increased the levels of intracellular ROS production detected by DCF fluorescence (green, left panels), and this was accompanied by significant increases in Nox2 expression (green, middle left panels), cell senescence (blue, middle right panels) and cell apoptosis (yellow, right panels). However, these changes were significantly inhibited in Nox2-KO cells.
Discussion
Aging is recognized as a normal biological process and is often associated with progressive oxidative stress in multiple organs [2, 3] . Although accumulating evidence has suggested that Nox2-derived ROS are involved in the oxidative damage of vascular function, the mechanisms (or factors) of Nox2 activation in normal aging remain unclear. This report using WT and Nox2KO mice of three distinct age groups (3-4 m, 11-12 m and 21-22 m) combined with a range of cellular and molecular approaches, revealed for the first time a crucial role for metabolic disorders (in particular hyperglycaemia and hyperinsulinaemia secondary to insulin resistance) in systemic Nox2 activation, vascular inflammation and endothelial dysfunction in aging.
One of the common pathophysiological manifestations in human aging is a declining regulation of glucose metabolism [3, 22] . In accordance with previous reports, we found that WT mice developed hyperglycaemia and hyperinsulinaemia starting in middle age and worsening at old age, when the levels of fasting serum glucose and insulin were nearly two-fold and four-fold of the levels of WT young mice, respectively. The novelty of the current study is that we showed a global Nox2 activation (not restricted in the endothelium) in response to aging-associated hyperglycaemia and hyperinsulinaemia as demonstrated by an age-related increase in the levels of Nox2-derived ROS production in several vital organs of WT mice including the heart, aorta, lung, spleen, kidney, brain, and bone marrow. We also demonstrated a positive feedback loop between progressive Nox2 activation in a high glucose/insulin environment and Nox2-derived oxidative stress causing further damage to the global metabolism in aging. Knockout of Nox2 or inhibiting Nox2 not only reduced the levels of aging-associated ROS production in these organs but also prevented metabolic syndrome and preserved endothelial function in old age.
Mouse aorta is a well-established and mostly used organ for studying metabolic or aging-related large vessel dysfunction [23] . An important discovery in the current study is that reduced IR expression and IR signaling (Akt phosphorylation) in aging aortas together with inflammation and oxidative damage of endothelial function. Using three complementary techniques (lucigenin-chemiluminescence, in situ DHE fluorescence and SOD-inhibitable cytochrome c reduction assay), we demonstrated that aging aortas produced~2 folds more ROS than young controls and this was accompanied by profound endothelial dysfunction and high blood pressure. The impaired endothelial dependent vessel relaxation was related to oxidative stress because addition of superoxide scavenger (tiron or MnTMPyP) in the organ bath restored the endothelial function. Furthermore, knockout of Nox2 completely abolished aorta ROS production and restored IR expression and signaling in old age. The crucial role of metabolic disorder-induced Nox2 activation and oxidative damage of endothelial function was further demonstrated using an accelerated aging model of HFD-induced obesity and insulin resistance of mice at 12 m of age, which is equivalent to a human of~50 years old when most metabolic and vascular diseases occur [1, 21, 23] . Once again we showed that inhibition of Nox2 activity using apocynin significantly reduced HFD-induced high blood pressure and aorta oxidative stress and preserved endothelial function.
High glucose and insulin are potent activators of the endothelial Nox2 enzyme [3, 4] . The current study extends our understanding of insulin resistance in vascular aging by showing that high glucose/ insulin via Nox2 stress signaling pathways promotes premature endothelial cell aging. In response to high glucose and insulin challenge, WT endothelial cells increased ROS production, which resulted in ERK1/2 activation, p53 expression and endothelial cell senescence and apoptosis. Knockout of Nox2 not only abolished high glucose/ insulin-induced ROS production but also protected endothelial cells from premature senescence and apoptosis. Although the relevance of in vitro senescence to organismal aging remains unclear, our in vitro data are in support of our in vivo observation that Nox2 plays a crucial role in glucose metabolic disorder-associated oxidative damage of endothelial cells and vascular aging.
The catalytic subunit of NADPH oxidase has 7 isoforms viz. Nox1-5, and Duox1-2 [24] . Among these Nox isoforms, Nox2 and Nox4 are largely expressed in the endothelium [6, 25] . Nox2 has been found to be involved in vascular inflammation and atherosclerotic lesion formation [26] , whereas Nox4 has been reported to play a protective role in vascular function [27] . The current study extended our understanding of NADPH oxidase by showing an aging-associated increase in Nox2 expression and a decrease in Nox4 expression in WT aging aortas. The mirror image of Nox2 and Nox4 expressions in aging aortas were accompanied by a significant increase in ERK1/2 activation and reduction in p38MAPK activation. Although the redox-signaling pathways underlying vascular aging remain unclear, it is possible that Nox2 signaling through ERK1/2 is involved in aging-associated deterioration of endothelial function. However, in the absence of Nox2, we found a significant increase of Nox4 expression in aging Nox2KO aorta, which might be a compensatory response. Compensatory increase in Nox4 in the deficiency of Nox2 had been reported previously in endothelial cells 
L.M. Fan et al. Free Radical Biology and Medicine 108 (2017) 940-951
Founding This work was supported by the research grants from the AgeUK (grant number: RIA 359) and the British Heart Foundation (grant number: PG/14/85/3116) awarded to JML.
